Abstract
Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.
Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.
Current Pharmaceutical Design
Title:Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]
Volume: 20 Issue: 14
Author(s): Takashi Ando and Atsuhiro Ichihara
Affiliation:
Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.
Abstract: Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.
Export Options
About this article
Cite this article as:
Ando Takashi and Ichihara Atsuhiro, Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR], Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113199990472
DOI https://dx.doi.org/10.2174/13816128113199990472 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
Current Drug Targets - Cardiovascular & Hematological Disorders A Review on Phytochemistry and Pharmacology of Medicinal as well as Poisonous Mushrooms
Mini-Reviews in Medicinal Chemistry CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Seaweed Proteins as a Source of Bioactive Peptides
Current Pharmaceutical Design Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome
Current Molecular Medicine Patent Selections
Recent Patents on Cardiovascular Drug Discovery Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Current Vascular Pharmacology GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
Current Cardiology Reviews The Role of Omega-3 Polyunsaturated Fatty Acids Supplementation in Childhood: A Review
Recent Patents on Cardiovascular Drug Discovery Factors Affecting 30-Day Mortality in Chinese Patients with Acute Myocardial Infarction: A Registry-Based Cohort Study
Vascular Disease Prevention (Discontinued) Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Current Neuropharmacology The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected by the Metabolic Syndrome: Evidences and Perspectives
Current Enzyme Inhibition Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design Cathelicidins: Peptides with Antimicrobial, Immunomodulatory, Anti- Inflammatory, Angiogenic, Anticancer and Procancer Activities
Current Protein & Peptide Science Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Neurodevelopmental Delay and Intellectual Disability in Pediatric Heart Transplant
Current Psychiatry Reviews Bone Marrow Cell Therapy in Clinical Trials: A Review of the Literature
Reviews on Recent Clinical Trials Energy Metabolism in the Normal and in the Diabetic Heart
Current Pharmaceutical Design